Cannabis distillate – vacuum-pure cannabinoids

TL;DR

• Short-path distillation separates cannabinoids from everything else.
• Purity 90-99 % (THC or CBD).
• Taste- and odour-neutral – ideal for encapsulation.
• No entourage effect (terpenes and minor cannabinoids absent).

What distillate is used for

• Precisely dosed edibles (mg-accurate).
• Softgel capsules and tablets.
• Vape cartridges (often re-formulated with botanical terpenes).
• Pharma feedstock (base of many Swissmedic formulations).

Purity versus aroma: when distillate makes sense

Distillate is a highly pure, largely terpene-free cannabinoid concentrate, usually with an active ingredient content of over 80 %. The advantage lies in the precise dosing — for capsules, oils, and vape liquids, a reproducible amount of active ingredient is more important than a full aroma profile. The disadvantage is the loss of the terpene spectrum; manufacturers therefore often reintroduce botanical terpenes, which should be stated on the declaration.

In terms of price, distillate is the most cost-effective form per milligram of active ingredient: when comparing CBD oil, it makes sense to calculate in francs per 100 mg of CBD instead of francs per bottle. For distillate-based oils, this value is typically significantly lower than that of full-spectrum products.

Quality testing for concentrates

For distillate, two analyses are relevant: the cannabinoid profile and the residual solvent test. If the latter is missing, nothing can be said about the purity in the case of solvent-based production. In addition, the total THC value of the end product should be documented as below 1 % — for concentrates, this is the most critical point under Swiss law.

• Batch number on the Certificate of Analysis (COA) — it must match the purchased package
• Total THC declared (THC + THCA × 0.877), not just delta-9-THC
• Analysis date less than twelve months old, laboratory with SAS accreditation or ISO/IEC 17025
• Harvest or production date declared — the most important freshness indicator for flowers

The technical process of vacuum distillation

The extraction of highly pure cannabis distillate is based on the precise separation of chemical compounds through different boiling points. Since cannabinoids only boil at very high temperatures under atmospheric pressure, at which they would be thermally damaged, a strong vacuum is applied in the laboratory. By lowering the pressure, the boiling point of the target molecules drops drastically. This enables gentle evaporation without thermally degrading the sensitive active ingredients such as CBD or THC or creating unwanted by-products.

In the actual distillation process, often using a rotary evaporator or thin-film evaporator, the vaporized active ingredient travels a short distance directly to a cooling surface. There, the purified cannabinoid condenses and flows off as a highly viscous, golden-yellow distillate. Residues such as plant fats, waxes, chlorophyll, and low-volatility impurities remain in the evaporator flask. This physical purification step requires precise temperature controls to cleanly separate the individual fractions and ensure the maximum purity of the final product.

• Lowering the boiling point through targeted vacuum control in the system
• Gentle vaporization prevents the thermal decomposition of cannabinoids
• Effective separation of low-volatility plant fats, waxes and colorants
• Condensation on cooling surfaces yields a highly viscous, golden-yellow end product

Swiss legislation for THC and CBD distillates

In Switzerland, cannabis distillates are subject to a strict legal classification based primarily on the total THC content. If this value, which is calculated from active THC and the precursor THCA, is below the limit of 1.0 percent, the distillate does not fall under the Narcotics Act. Such CBD distillates can be legally traded and processed. However, as soon as the total THC content reaches or exceeds this threshold, the concentrate is considered an illegal narcotic, unless it is a medical distillate.

Since the amendment to the law in August 2022, Swiss physicians can prescribe medical cannabis preparations, including THC-containing distillates and formulations based on them, directly and without exceptional authorization from the Federal Office of Public Health (BAG). For consumers in everyday life, the strict road traffic regulations are also relevant: since an extremely low detection limit of 1.5 micrograms of THC per liter applies in the blood, the consumption of THC-containing distillates inevitably leads to unfitness to drive.

• A total THC limit of under 1 percent determines legality in the free market
• Medical cannabis based on distillates has been regularly prescribable by doctors since August 2022
• Strict zero-tolerance practice in Swiss road traffic with a limit value of 1.5 µg/L of blood
• Depending on the product category, responsibilities lie with the BAG, the BLV or Swissmedic

Risks and safety aspects of dosing

The extreme concentration of cannabinoids in distillates poses specific risks during handling and dosing in both private and commercial sectors. Since even tiny amounts of just a few milligrams exert a highly potent effect, a precise milligram scale is mandatory for processing. Compared to conventional flowers or weaker oils, inaccurate estimation by eye leads extremely quickly to a massive overdose, which can trigger unpleasant psychoactive effects or physical side effects.

In the event of accidental overconsumption or symptoms of poisoning caused by highly concentrated distillates, the national emergency number of Tox Info Suisse (telephone 145) provides professional medical advice around the clock. In addition to the risk of dosing, low-quality distillates carry a risk of residual solvents from the extraction process. Since alcohols or hydrocarbons are often used for primary extraction, these must be completely removed in the laboratory. Consumers should therefore only purchase products whose freedom from contaminants is seamlessly documented by independent Swiss laboratories.

• High active ingredient density strictly requires the use of calibrated precision scales
• Increased risk of accidental overdose compared to raw flowers
• Tox Info Suisse (emergency number 145) as the official point of contact for symptoms of poisoning
• Risk of residual solvents requires batch-specific laboratory analyses

Reconstruction with terpenes in practice

Since all volatile terpenes are lost during distillation, the end product is initially odorless and tasteless. To restore the typical aroma of cannabis or to achieve specific sensory properties, manufacturers often add terpenes back to the distillate afterwards. A distinction is made between cannabis-derived terpenes, which are obtained directly from the cannabis plant, and botanical terpenes from other plants such as lavender, pine, or citrus fruits. The latter are more cost-effective, but usually replicate the complex profile of the original plant less accurately.

The addition of terpenes not only influences the taste, but also changes the physical properties of the distillate. Pure distillate is extremely viscous to solid at room temperature, which makes it difficult to use in vaporizers. Terpenes act as natural diluents and lower the viscosity, allowing the mixture to flow optimally in vape cartridges. However, caution is advised during production, as an excessively high terpene concentration can irritate the respiratory tract and statutory product safety requirements must be met.

• Subsequent addition of terpenes restores the lost aroma profile
• Distinction between expensive cannabis-derived and cheaper botanical terpenes
• Terpenes lower the viscosity of the viscous distillate for vape use
• Excessively high concentrations of added terpenes can severely irritate the respiratory tract

FAQ